UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (32) 32
hygiene (32) 32
medical or veterinary science (32) 32
preparations for medical, dental, or toilet purposes (32) 32
specific therapeutic activity of chemical compounds ormedicinal preparations (27) 27
life sciences & biomedicine (10) 10
science & technology (10) 10
acute coronary syndromes (8) 8
humans (8) 8
abridged index medicus (7) 7
cardiac & cardiovascular systems (7) 7
cardiovascular system & cardiology (7) 7
acute coronary syndrome (6) 6
alirocumab (6) 6
coronary heart disease (6) 6
male (6) 6
acute coronary syndrome - drug therapy (5) 5
aged (5) 5
anticoagulants (5) 5
cardiovascular (5) 5
double-blind method (5) 5
female (5) 5
middle aged (5) 5
mortality (5) 5
treatment outcome (5) 5
acute coronary syndrome - complications (4) 4
care and treatment (4) 4
drug therapy (4) 4
drug therapy, combination (4) 4
heart attacks (4) 4
adult (3) 3
analysis (3) 3
angina pectoris (3) 3
cardiology and cardiovascular medicine (3) 3
cardiovascular disease (3) 3
chemistry (3) 3
cholesterol (3) 3
death (3) 3
heterocyclic compounds (3) 3
internal medicine (3) 3
metallurgy (3) 3
organic chemistry (3) 3
statins (3) 3
acute coronary syndrome - mortality (2) 2
angina (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
cardiac and cardiovascular systems (2) 2
cardiology (2) 2
cardiovascular diseases (2) 2
cardiovascular diseases - prevention & control (2) 2
cerebral infarction (2) 2
cerebrovascular disease (2) 2
cholesterol, ldl - blood (2) 2
clinical trials (2) 2
confidence intervals (2) 2
coronary artery disease (2) 2
coronary vessels (2) 2
cyclic n-oxides - adverse effects (2) 2
diabetes (2) 2
factor xa inhibitors (2) 2
follow-up studies (2) 2
glycosaminoglycans (2) 2
health risk assessment (2) 2
heart diseases (2) 2
hospitalization (2) 2
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (2) 2
hypercholesterolemia - drug therapy (2) 2
ischemia (2) 2
kardiologi (2) 2
major adverse cardiac events (2) 2
monoclonal antibodies (2) 2
myocardial infarction (2) 2
myocardial infarction - etiology (2) 2
myocardial infarction - prevention & control (2) 2
patient outcomes (2) 2
patients (2) 2
peripheral artery disease (2) 2
pyridines - adverse effects (2) 2
risk (2) 2
stroke (2) 2
total events (2) 2
usage (2) 2
10021 (1) 1
10034 (1) 1
10072 (1) 1
10161 (1) 1
610 medicine & health (1) 1
acute coronary syndrome - blood (1) 1
acyclic or carbocyclic compounds (1) 1
adolescent (1) 1
aged patients (1) 1
aged, 80 and over (1) 1
analysis and chemistry (1) 1
angina, unstable - prevention & control (1) 1
antibodies, monoclonal, humanized (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
anticholesteremic agents - therapeutic use (1) 1
anticoagulants - adverse effects (1) 1
anticoagulants - therapeutic use (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (54) 54
Spanish (10) 10
French (7) 7
Chinese (3) 3
German (2) 2
Korean (2) 2
Arabic (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The American heart journal, ISSN 0002-8703, 11/2014, Volume 168, Issue 5, pp. 682 - 689.e1
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2019, Volume 73, Issue 4, pp. 387 - 396
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2019, Volume 74, Issue 9, pp. 1167 - 1176
textabstractrisk of major adverse cardiovascular events (MACEs) and death. The impact of lipid lowering by proprotein convertase subtilisin–kexin type 9... 
major adverse cardiac events | alirocumab | acute coronary syndrome | cerebrovascular disease | peripheral artery disease | death | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular Diseases - etiology | Dyslipidemias - drug therapy | Vascular Diseases - prevention & control | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Dyslipidemias - complications | Risk Assessment | Vascular Diseases - etiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Treatment Outcome | Vascular Diseases - epidemiology | Acute Coronary Syndrome - complications | Cardiovascular Diseases - epidemiology | Female | Aged | Care and treatment | Coronary heart disease | Patient outcomes | Analysis | Myocardial infarction | Therapy | Heart attacks | Dyslipidemia | Cardiovascular disease | Lipids | Angina | Incidence | Confidence intervals | Reduction | Ischemia | Atherosclerosis | Cardiology | Heart diseases | Statins | Cerebral infarction | Evaluation | Stroke | Medical treatment | Mortality | Health risks | Risk reduction | Subtilisin | Angina pectoris | Coronary artery disease | Kexin | Arteriosclerosis | Coronary vessels | Death | Diabetes | Acute coronary syndromes | Risk management | Cardiovascular diseases | Health risk assessment | Index Medicus | Abridged Index Medicus
Journal Article
by Szarek, Michael and Budaj, Andrzej J and Diaz, Rafael and Hanotin, Corinne and Harrington, Robert A and Tuñón, José and Zeiher, Andreas M and Schwartz, Gregory G and Steg, Ph. Gabriel and Drexel, Heinz and Liberopoulos, Evangelos and Montenegro Valdovinos, Pablo Carlos and Tse, Hung-Fat and Kim, Sang-Hyun and Laucevicius, Aleksandras and Alings, Marco and Halvorsen, Sigrun and Morais, Joao and Fras, Zlatko and de Silva, H. Asita and Sritara, Piyamitr and Guneri, Sema and Moriarty, Patrick M and Simoons, Maarten L and Meloni, Chiara and Sijbrands, Eric J.G and Bagai, Akshay and Bahit, Maria Cecilia and Brennan, J. Matthew and DeVore, Adam D and Ducrocq, Grégory and Eapen, Zubin and Endsley, Patricia and Harrison, Robert W and Hlatky, Mark A and Kong, David F and Leonardi, Sergio and Lillis, Linda and Maron, David J and Patel, Chetan B and Sujjavanich, Darin and Wilson, Matthew D and Alvarisqueta, Andrés F and Duronto, Ernesto A and Montaña, Oscar R and Gomez Vilamajo, Oscar A and Paterlini, Gustavo A and Salomone, Oscar and Hrabar, Adrian D and Dran, Ricardo D and Vico, Marisa L and Garcia Brasca, Daniela F and Liberman, Alberto and Luciardi, Hector L and Waisman, Gabriel D and Garcia Duran, Ruben O and Cestari, Horacio G and Zapata, Gerardo and Waites, Jonathon H and Arstall, Margaret A and Rogers, James F and Colquhoun, David and Garrahy, Paul J and Delle-Karth, Georg and Faes, Dirk and Wollaert, Bart and Dujardin, Karl and Beauloye, Christophe and Barakovic, Fahir and Kulić, Mehmed and Silva, Ricardo P and Duda, Norberto and Kormann, Adrian and de Santos, Mayler ON and Eliaschewitz, Freddy G and Botelho, Roberto V and Manenti, Euler Roberto Fernandes and Moura Jorge, Jose C and Silveira, Jose A and de Souza, Juliana A and Machado, Leandro and Ayoub, José Carlos Aidar and Nikolov, Fedya P and Velcheva, Elena S and Raev, Dimitar H and Pesant, Yves and Hoag, Gordon and Kouz, Simon and Diaz, Ariel and Leung, Raymond and Vuurmans, Tycho and Lai, Christopher and Vijayaraghavan, Ram and Dupuis, Robert and Fadlallah, Hussein and Hameed, Adnan and Vejar, Margarita and Huidobro, Laura and Olivares, Claudia and Nahuelpan, Leonardo and ... and ODYSSEY OUTCOMES Committees and Investigators and ODYSSEY OUTCOMES Comm Investigato
The lancet. Diabetes & endocrinology, ISSN 2213-8587, 08/2019, Volume 7, Issue 8, pp. 618 - 628
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2020, Volume 75, Issue 18, pp. 2297 - 2308
BACKGROUND Cholesterol reduction with proprotein convertase subtitisin-kexin type 9 inhibitors reduces ischemic events; however, the cost-effectiveness in... 
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2019, Volume 74, Issue 9, pp. 1167 - 1176
Patients with acute coronary syndrome (ACS) and concomitant noncoronary atherosclerosis have a high risk of major adverse cardiovascular events (MACEs) and... 
major adverse cardiac events | alirocumab | acute coronary syndrome | cerebrovascular disease | peripheral artery disease | death
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2019, Volume 73, Issue 4, pp. 387 - 396
The ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab) trial compared alirocumab with... 
alirocumab | total events | acute coronary syndrome
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A13393 - A13393
IntroductionIn ODYSSEY OUTCOMES, first occurrence of coronary heart disease (CHD) death, myocardial infarction (MI), fatal/nonfatal ischemic stroke, or... 
Journal Article
03/2017
The invention relates to otamixaban or a pharmaceutically acceptable salt thereof for use in the treatment of non-ST elevation acute coronary syndrome in... 
HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
07/2015
The invention relates to otamixaban or a pharmaceutically acceptable salt thereof for use in the treatment of non-ST elevation acute coronary syndrome in... 
HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent